PDF
ePub
Citation
Print
Abstract
Rheumatic manifestations are common clinical problems in patients with diabetes, especially in patients with long disease duration and poor glycemic control. The pathogenesis of rheumatic diseases in diabetes is still unclear, however, several factors can contribute to the disease such as microvascular injury, the accumulation of advanced glycation end-products, the complications of diabetic polyneuropathy, genetic predisposition, and shared common risk factors. The rheumatic conditions that are reviewed in this article include diabetic cheiroarthropathy, trigger finger, Dupuytren's contracture, carpal tunnel syndrome, adhesive capsulitis, diffuse idiopathic skeletal hyperostosis, neuropathic arthropathy, and gouty arthritis. The incidence of common rheumatic diseases, such as osteoarthritis and rheumatoid arthritis, is not increased in patients with diabetes. Because rheumatic conditions affect quality of life and functions of diabetes patients, physicians need to pay attention to clinical manifestations, diagnosis and management of these rheumatic diseases.
References
1. Al-Homood IA. Rheumatic conditions in patients with diabetes mellitus. Clin Rheumatol. 2013; 32:527–33.
2. Jacobs-Kosmin D, DeHoratius RJ. Musculoskeletal manifestations of endocrine disorders. Curr Opin Rheumatol. 2005; 17:64–9.
3. Burner TW, Rosenthal AK. Diabetes and rheumatic diseases. Curr Opin Rheumatol. 2009; 21:50–4.
4. Shih B, Bayat A. Scientific understanding and clinical management of Dupuytren disease. Nat Rev Rheumatol.
5. Bañón S, Isenberg DA. Rheumatological manifestations occurring in patients with diabetes mellitus. Scand J Rheumatol. 2013; 42:1–10.
6. Pandey A, Usman K, Reddy H, Gutch M, Jain N, Qidwai S. Prevalence of hand disorders in type 2 diabetes mellitus and its correlation with microvascular complications. Ann Med Health Sci Res. 2013; 3:349–54.
7. Peimer CA, Blazar P, Coleman S, Kaplan FT, Smith T, Tursi JP, Cohen B, Kaufman GJ, Lindau T. Dupuytren contracture recurrence following treatment with collagenase clostridium histolyticum (CORDLESS study): 3-year data. J Hand Surg Am. 2013; 38:12–22.
8. Perkins BA, Olaleye D, Bril V. Carpal tunnel syndrome in patients with diabetic polyneuropathy. Diabetes Care. 2002; 25:565–9.
9. Makepeace A, Davis WA, Bruce DG, Davis TM. Incidence and determinants of carpal tunnel decompression surgery in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care. 2008; 31:498–500.
10. Huang YP, Fann CY, Chiu YH, Yen MF, Chen LS, Chen HH, Pan SL. Association of diabetes mellitus with the risk of developing adhesive capsulitis of the shoulder: a longitudinal population-based followup study. Arthritis Care Res (Hoboken). 2013; 65:1197–202.
11. HCrispin JC, Alcocer-Varela J. Rheumatologic manifestations of diabetes mellitus. Am J Med. 2003; 114:753–7.
12. Miranda H, Viikari-Juntura E, Heistaro S, Heliövaara M, Riihimäki H. A population study on differences in the determinants of a specific shoulder disorder versus nonspecific shoulder pain without clinical findings. Am J Epidemiol. 2005; 161:847–55.
13. Mader R, Lavi I. Diabetes mellitus and hypertension as risk factors for early diffuse idiopathic skeletal hyperostosis (DISH). Osteoarthritis Cartilage. 2009; 17:825–8.
14. Lee L, Blume PA, Sumpio B. Charcot joint disease in diabetes mellitus. Ann Vasc Surg. 2003; 17:571–80.
15. Chakravarty SD, Markenson JA. Rheumatic manifestations of endocrine disease. Curr Opin Rheumatol. 2013; 25:37–43.
16. Mascarenhas JV, Jude EB. Pathogenesis and medical management of diabetic Charcot neuroarthropathy. Med Clin North Am. 2013; 97:857–72.
17. Liu Q, Gamble G, Pickering K, Morton S, Dalbeth N. Prevalence and clinical factors associated with gout in patients with diabetes and prediabetes. Rheumatology (Oxford). 2012; 51:757–9.
18. Lai HM, Chen CJ, Su BY, Chen YC, Yu SF, Yen JH, Hsieh MC, Cheng TT, Chang SJ. Gout and type 2 diabetes have a mutual inter-dependent effect on genetic risk factors and higher incidences. Rheumatology (Oxford). 2012; 51:715–20.
XML Download